SPACE TANGO LLC
Automated microgravity research and manufacturing platform for conducting experiments and producing materials in space
- Sector
- Biotech
- Headquarters
- LEXINGTON, KY
- Latest Form D
- $150K, Nov 2017
- Total capital
- $2.5M
- Federal grants
- $1.3M
- 3 awards · 2024
- Rank in peer group#6 of 12
- Private capital raised
- $225K
- 2 Form D · last Nov 2017
- 107 months since last filing
- Federal contracts
- $998K
- 2 awards · NASA
- Rank in Biotech#189 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantNASA · Phase II · SBIR Phase Ii-ignite - Tangobox: Demonstration Of Next Generation Infrastructure For In-space Research And Production$849K
- Federal contractNASA · SBIR Phase Ii-ignite - Tangobox: Demonstration Of Next Generation Infrastructure For In-space Research And Production$849K
- Federal grantNSF · Phase I · SBIR Phase I: Consortium for High Throughput CubeLab by Space Tango$275K
- Federal grantNASA · Phase I · Tangobox: Next Generation Infrastructure For In-space Production On Commercial Spacestations$149K
- Federal contractNASA · Tangobox: Next Generation Infrastructure For In-space Production On Commercial Spacestations$149K
- Private capital raisedForm D · SEC · 2nd filing$150K
- Private capital raisedForm D · SEC · 1st filing$75K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 12 peers
Line = medianBiotech · System
- Federal grants#6 · top 50%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Twyman ClementsResearcherExecutive OfficerLinked by $275K in grants as PI
- Frank SamuelDirectorNamed in SEC Form D filings
- Kris KimelDirectorNamed in SEC Form D filings
- Lee ToddDirectorNamed in SEC Form D filings
- Mark KristyDirectorNamed in SEC Form D filings
- Ron GeogheganDirectorNamed in SEC Form D filings
Show all 8 people
- Sam BurchettDirectorNamed in SEC Form D filings
- Susan WeissDirectorNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- OXFORD BIOMEDICAL RESEARCH, INC.Similar federal contract value in Biotech · $1M in contracts
- Gliknik IncSimilar federal contract value in Biotech · $1M in contracts
- Flow Pharma, Inc.Similar federal contract value in Biotech · $1.0M in contracts
- DIANT PHARMA INCSimilar federal contract value in Biotech · $995K in contracts
- LUCIGEN CORPORATIONSimilar federal contract value in Biotech · $994K in contracts
- PAK BIOSOLUTIONS, INC.Similar federal contract value in Biotech · $942K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .